Lucid Diagnostics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Lucid Diagnostics Inc. (LUCD) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $1.70 per share as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-08-12
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $1.70.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $1.74.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $1.76.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $1.82.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $1.70 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.74 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.76 10-K · filed 2026-03-25 |
| 2025-09-30 | $1.82 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.87 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.93 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.02 10-K · filed 2025-03-24 |
| 2024-09-30 | $2.19 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.26 10-Q · filed 2024-08-12 |
| 2024-03-31 | $2.29 10-Q · filed 2024-05-13 |
| 2023-12-31 | $2.30 10-K · filed 2024-03-25 |
| 2023-09-30 | $2.77 10-Q · filed 2023-11-13 |
| 2022-06-30 | $1.90 10-Q · filed 2022-08-15 |
| 2022-03-31 | $0.99 10-Q · filed 2022-05-16 |
| 2021-12-31 | $0.61 10-K · filed 2022-04-06 |
| 2021-06-30 | $0.57 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |